Q1 2023 ACADIA Pharmaceuticals Inc Earnings Call Transcript
Good day, ladies and gentlemen. Thank you for standing by. Welcome to ACADIA Pharmaceuticals First Quarter 2023 Financial Results Conference Call. My name is Corey, and I will be your coordinator for today.(Operator Instructions)
Please be advised today's conference call is being recorded. I would now like to turn the presentation over to Mark Johnson, Vice President of Investor Relations at ACADIA. Please proceed.
Thank you. Good afternoon, and thank you for joining us on today's call to discuss ACADIA's first quarter 2023 financial results. Joining me on the call today from ACADIA are Steve Davis, our Chief Executive Officer, who will provide an overview of our performance and review of our business; Brendan Teehan, our Chief Operating Officer, Head of Commercial, will provide updates on our recent launch of DAYBUE for the treatment of Rett syndrome followed by commercial updates on our NUPLAZID franchise; Doug Williamson, our Head of R&D, will provide an update of our pipeline programs, and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |